Definitive Healthcare financials
$0.9300+1.61%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $241.5M | $252.2M | $251.4M | $222.7M | $166.2M |
| Gross profit | $183.3M | $197.5M | $203.9M | $180.0M | $125.5M |
| Gross margin | 75.9% | 78.3% | 81.1% | 80.9% | 75.5% |
| Operating income | -$224.3M | -$710.8M | -$329.8M | -$44.0M | -$27.3M |
| Net income | -$138.9M | -$413.1M | -$202.4M | -$7.2M | -$17.8M |
| Net margin | −57.5% | −163.8% | −80.5% | −3.2% | −10.7% |
| Diluted EPS | $-1.30 | $-3.54 | $-1.79 | $-0.07 | $-0.19 |
| EBITDA | $51.4M | $57.4M | $33.8M | $29.6M | $43.7M |
| Operating cash flow | $53.8M | $58.2M | $41.2M | $35.6M | $25.2M |
| Free cash flow | $37.1M | $45.9M | $38.2M | $27.3M | $18.5M |
| Diluted shares | 106.7M | 116.6M | 112.8M | 101.1M | 91.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $163.6M | $105.4M | $131.0M | $146.9M | $387.5M |
| Short-term investments | $17.3M | $184.8M | $177.1M | $184.9M | $0.00 |
| Total debt | $164.8M | $243.1M | $256.3M | $264.4M | $270.7M |
| Total assets | $735.5M | $1.09B | $1.83B | $2.12B | $2.12B |
| Total liabilities | $356.5M | $482.2M | $626.7M | $640.7M | $617.8M |
| Shareholders' equity | $379.0M | $607.2M | $1.20B | $1.48B | $1.50B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology